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Background. Afebrile Plasmodium falciparum infections usually remain undetected and untreated in the community and could 
potentially contribute to sustaining local malaria transmission in areas aiming for malaria elimination.
Methods. Thirty-two men with afebrile P. falciparum infections detected with rapid diagnostic test (RDTs) were followed for 
28 days. Kaplan-Meier estimates were computed to estimate probability of parasite positivity and of reducing parasitemia by half of 
its initial level by day 28. Trends of parasite densities quantified by microscopy and real-time quantitative polymerase chain reaction 
(qPCR) were assessed using Poisson regression models, and the microscopy-to-qPCR positivity ratio was calculated at each time 
point. Three survival distributions (Gompertz, Weibull, and gamma) were used to evaluate their strength of fit to the data and to 
predict the median lifetime of infection.
Results. The cumulative probability of parasite qPCR positivity by day 28 was 81% (95% confidence interval [CI], 60.2–91.6). 
Geometric mean parasitemia at recruitment was 516.1 parasites/μL and fell to <100 parasites/μL by day 3, reaching 56.7 parasites/μL 
on day 28 (P < .001). The ratio of P. falciparum–positive samples by microscopy to qPCR decreased from 0.9 to 0.52 from recruitment 
to day 28. The best model fit to the data was obtained assuming a Gompertz distribution.
Conclusions. Afebrile P. falciparum infections detectable by RDT in semi-immune adults fall and stabilize at low-density levels 
during the first 4 days after detection, suggesting a rapid decline of potential transmissibility in this hidden parasite reservoir.
Clincial trials registration. NCT02698748
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Asymptomatic Plasmodium falciparum parasitemia is com-
monly defined as the presence of asexual parasites in the blood 
without symptoms or illness [1]. These infections, which can be 
either detectable using standard diagnostic tests such as micros-
copy or rapid diagnostic tests (RDTs) or submicroscopic if iden-
tified only by molecular techniques, are usually characterized 
by the absence of fever and can, therefore, be more specifically 
referred to as afebrile infections. Although fever-less infections 
may still cause other less evident symptoms with a substantial 
burden on the infected individual’s health [2], individuals with 
afebrile malaria infections usually do not seek clinical atten-
tion and therefore remain undetected by passive surveillance 
systems [3]. Proactive community cross-sectionals conducted 
to assess parasite prevalence rates have reported varying preva-
lence estimates of afebrile infections [4–6], indicating that these 
infections are highly prevalent in the community and could 
contribute to sustaining malaria transmission [7].
Albeit poorly understood, there are several parasite and host 
factors that could contribute to maintaining high community 
rates of afebrile malaria infections [3]. In high-endemic areas, 
exposed individuals develop a level of tolerance to P. falciparum 
infections into adulthood through which the pathogenesis of the 
infection is minimized while the parasite densities remain rela-
tively low [8], thus leading to afebrile and submicroscopic infec-
tions. Although the relative contribution of silent parasite carriers 
with low parasitemia to overall transmission is still unknown [9], 
the high prevalence and prolonged duration [10, 11] of these 
infections, as well as their continuous production of gameto-
cytes [12, 13], may imply that these infections are an important 
source for transmission. Additionally, such infections may pose 
challenges when monitoring malaria elimination in historically 
endemic areas where no further clinical cases are detected but 
where residual immunity among human hosts can still lead to the 
silent persistence of the parasite population [5, 14].
Several observational studies conducted in the early 1900s 
in malaria-endemic countries to quantify the durability of 
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P. falciparum infections found that infections detected by micros-
copy lasted from a few weeks up to several years and that para-
site densities and symptoms were reduced soon after the onset of 
infection [15–19]. However, the wide differences in host immunity 
among study participants, the limited sensitivity of microscopy, 
and the lack of genetic tools to identify reinfections that could 
occur during follow-up in areas of ongoing transmission [18, 20, 
21] hinder the interpretation of these studies. More recently, the 
use of molecular techniques has allowed a more accurate charac-
terization of the dynamics and duration of infection from a single 
parasite strain [18, 22–26], primarily showing that the longevity of 
infections decreased with increasing age [23, 26].
A better understanding of natural dynamics of afebrile P. falci-
parum infections is needed to design effective interventions that 
can successfully detect and tackle this parasite reservoir at com-
munity level [3]. Herein, parasite infections were longitudinally 
assessed in untreated afebrile adults from a perennially endemic 
region in southern Mozambique using molecular methods and 
mathematical models to better characterize dynamics of these 
silent P.  falciparum infections and contribute to the ongoing 




Adult men with afebrile P.  falciparum infections recruited 
between January 2015 and June 2015 were treated with placebo 
and observed for 28 days in the context of a randomized, place-
bo-controlled clinical trial conducted in the district of Manhiça 
(southern Mozambique) [27]. This period coincided with the 
high malaria transmission season in the area, which is perennial 
but more marked during the rainy period (between November 
and April) [28]. The study aimed to assess the efficacy of chlo-
roquine (CQ) to clear asymptomatic infections among healthy 
adults from the community. A placebo comparator was used to 
accurately account for the effect that the high levels of immu-
nity expected in the study population would have on natural 
parasite clearance of low-level parasitemia infections. This anal-
ysis aimed to characterize the dynamics of afebrile infections 
in participants enrolled in the placebo group. Individuals who 
developed fever at any time during follow-up or who were only 
followed up for 1 day were excluded from this analysis.
Sample Collection and Analysis
Healthy men were screened at the household level using a 
Histidine Rich Protein 2 (HRP2)–based rapid diagnostic test 
(RDT) from SD Bioline. All positive cases by RDT were sub-
sequently confirmed by expert microscopy at the Centro de 
Investigação em Saúde de Manhiça (CISM). Asymptomatic 
malaria was defined as the absence of any proactively referred 
symptom of disease according to the screened individual, 
together with a documented axillary temperature <37.5°C. 
Enrolled individuals were randomly assigned to the CQ or pla-
cebo arm and followed up on days 1, 2, 3, 7, 14, 21, and 28 after 
enrollment. All individuals in the placebo group were treated at 
the end of follow-up according to national guidelines, and rescue 
treatment was administered to participants of either study arm 
that presented with clinical symptomatology during follow-up. 
Thick and thin Giemsa-stained blood slides and 50 µL of blood 
spotted onto filter papers were collected at every visit.
Slides were examined by 2 independent microscopists and 
considered negative if no parasites were seen after examina-
tion of 200 oil-immersion fields in a thick blood film. A third 
read was conducted in cases where the first 2 readings were 
discrepant. Parasite density was estimated using the Lambaréné 
method [29], which counts parasites against an assumed known 
blood volume. Density of P. falciparum was also assessed from 
filter paper blood-spots through real-time quantitative poly-
merase chain reaction (qPCR) assay targeting 18S ribosomal 
RNA [30]. Parasitemia was quantified by extrapolation of cycle 
thresholds (Ct) from a standard curve of P. falciparum 3D7 in 
vitro culture ring stage. Samples without amplification (no Ct 
detected) were considered negative. A negative control with no 
template DNA was run in all reactions.
Data Analysis
Data from participants assigned to the placebo group were ana-
lyzed using Stata 14 (Stata Corp, College Station, TX, USA) and 
R Statistical Software (version 3.3.1, R Foundation for Statistical 
Computing, Vienna, Austria). Basic characteristics of participants 
at enrollment were summarized using arithmetic or geometric 
means and medians, as determined by the distribution of the data. 
Kaplan-Meier estimates were computed to measure the cumula-
tive probabilities of parasite positivity by day 28 and of failure to 
reduce parasitemia levels by at least 50% of their initial value by 
day 28—or half-life probability. An infection was considered to 
be cleared at the time of the first negative observation by qPCR 
and when parasites were no longer observed for the subsequent 
follow-up observations. For infections in which parasite densities 
were reduced by >50% of their initial value by the end of follow-up, 
the last time point at which parasite densities were observed to fall 
below this threshold was considered as the time at which half-life 
was reached. Geometric mean parasite densities (GMPDs) and 
95% confidence intervals (CIs) were calculated for each day of fol-
low-up. A Poisson regression random-effect model was used to 
measure the variation of the parasite densities measured by qPCR 
at each day of follow-up. Finally, the proportions of infections that 
were positive by qPCR or by microscopy were calculated, and a 
ratio of positive microscopy to qPCR samples was estimated.
Evaluation of Natural Infection Distributions
We evaluated the strength of fit to the data of 3 survival distri-
butions considered by previous groups to model natural malaria 
infections (Gompertz, Weibull, and gamma) [31, 32] in order 
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to provide consistent information to the ongoing discussion in 
this field. Kolmogorov-Smirnov test estimates were calculated 
to evaluate the strength of the fit of each of the distributions, 
and Akaike’s information criterion values were calculated for 
comparison of the model fits. We also attempted to estimate 
the median lifetime of infection and the probability of parasite 
positivity by day 28 using the abovementioned distributions, 
acknowledging the limitations of the data for this purpose, such 
as small sample size, short follow-up duration, or lack of ability 
to disentangle reinfections and recrudescence.
Ethical Considerations
The protocol, consent forms, and questionnaires were approved 
by the CISM local ethics committee, the Ethics Committee of 
the Hospital Clínic of Barcelona (HCB/2015/0122), the National 
Bioethics Committee of Mozambique (CNBS; Ref. 173/
CNBS/13) and the Mozambican Pharmaceutical Department 
(Ref./No. 4110/380/DF2014) before their implementation. All 
participants signed an informed consent form prior to the initi-
ation of any study related activities. The clinical trial was regis-
tered at www.ClinicalTrials.gov (NCT02698748).
RESULTS
This analysis used data from 32 of the 38 individuals originally 
enrolled in the placebo group of the clinical trial. Three individ-
uals with only a single follow-up observation and 3 individuals 
who developed a fever after day 1 (n = 1) or day 3 (n = 2) of 
follow-up were consequently excluded from this analysis. Three 
individuals had missing qPCR data (on days 0, 1, and 21 respec-
tively), and 9 skipped 1 day of follow-up (1 on day 2, 1 on day 3, 
4 on day 7, and 3 on day 21) (Supplementary Table 1).
The average age of participants at enrollment was 25 years. 
The median body temperature was 36.4ºC, and the average 
body weight was 55.6 kg. The geometric mean parasite density 
on day 0 was 733parasites/μL as measured by microscopy and 
516.1parasites/μL as measured by qPCR (Table 1).
The cumulative probability of parasite positivity by day 28 
based on qPCR diagnosis was 81.5% (95% CI, 61.1–91.9), with 
only 5 of the 32 individuals becoming negative by qPCR during 
follow up: 1 on day 2, 1 on day 14, 1 on day 21, and 2 on day 
28 (Figure 1). The GMPD of infections as quantified by qPCR 
dropped by 70% (risk ratio, 0.29; 95% CI, .29–.30) by the end of 
follow-up (Table 2). The GMPD on day 0 was 516.1 parasites/
μL and fell to <100 parasites/μL by day 3, reaching 56.7 para-
sites/μL on day 28 (P < .001) (Figure 2). Ten (31%) individuals 
successfully reduced parasitemia levels by at least 50% of their 
initial value within the first day of follow-up (Figure 3), and 5 
more did so by the 7th day of follow-up. By the end of the study, 
the half-life cumulative probability was 22% (95% CI, 9.3–38.9) 
as the initial parasitemia levels were sustainably halved in 23 of 
32 participants. Finally, in 4 of the 32 infections, parasite lev-
els increased during follow-up to levels higher than their initial 
value (participants 18, 23, 55 and 110 in Supplementary Table 1).
All infections detected by microscopy were also detected by 
qPCR. The ratio of positive samples by microscopy to qPCR 
decreased from 0.9 (n = 28/31) on day 0 to 0.52 (n = 11/21) on 
day 28 (Figure  4). Overall, the GMPD of positive samples by 
qPCR and microscopy was 351.1 parasites/μL (95% CI, 266.8–
462.1), and the parasite density among positive samples unde-
tected by microscopy was 13.8 parasites/μL (95% CI, 9.6–19.8).
The Akaike’s information criterion values obtained after mod-
eling the infection dynamics suggest that the best model fit to the 
data was obtained assuming a Gompertz distribution (Table 3). 
The Kolmogorov-Smirnov test results for all distributions showed 
a modest fit for the 3 distributions. The predicted proportion of 
individuals who would continue to be infected by day 28 ranged 
81%–82% for all distributions, and the estimated median life-
time was 41.6, 61.5, and 73.2 days as estimated by the Gompertz, 
Weibull, and gamma distributions, respectively (Table 3).
DISCUSSION
This longitudinal analysis of P.  falciparum–infected afebrile 
adults in southern Mozambique followed for 28  days after 
detection of infection by RDT shows that most study partic-
ipants remained infected until the end of the study without 
developing fever and were able to control parasite densities at 
submicroscopic levels after the first few days of follow-up, fol-
lowing a Gompertz distribution. These findings suggest a rapid 
decline of potential transmissibility and detectability of recently 
acquired infections in semi-immune individuals in endemic 
areas, offering novel information about natural parasite dynam-
ics that can be used to design malaria elimination interventions 
and model their impact.
Despite not achieving full parasite clearance, most individu-
als were able to halve their parasite densities within the 28-day 
follow-up period. In fact, parasite densities drastically decreased 
during the first 4  days of follow-up to levels below the typical 
microscopy and RDT detection threshold (100 parasites/μL) and 
Table 1. Basic Characteristics of Study Participants at Enrollment
Characteristic Summary Statistics
Agea 26 (14) 
n = 32
Body temperature, °Ca 36.4 (0.35) 
n = 32
Weight, kga 55.6 (11.2)
n = 32
Microscopy parasite density, p/μLb 733.0 (1088.0)
n = 28
qPCR parasite density, p/μLb 516.1 (872.9) 
n = 31
Abbreviation: qPCR, quantitative polymerase chain-reaction.
aStatistics are given as arithmetic mean (SD).
bStatistics are given as geometric mean (SD).
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remained below this parasitemia level until the end of the study. 
Similar patterns have been reported by Bruce-Chwatt et al, who 
measured daily parasitemia by microscopy after the acquisition 
of infection among Nigerian adults [16]. A study using an ultra-
sensitive PCR to monitor parasite densities monthly also showed 
that asymptomatic infections in adults decreased and remained 
at levels <100 parasites/μL [18], but there was no up-to-date-evi-
dence of the daily dynamics of infection in adults using molecular 
techniques. Our findings suggest that individuals from endemic 
areas, who have acquired some level of antiparasite immunity, are 
able to rapidly control infections within a few days after detection 
by RDT without completely clearing the infection by day 28.
Several studies have observed a direct association between 
asexual parasitemia and gametocyte carriage [33]. In this con-
text, our results suggest that asymptomatic infections in adults 
have a short period (3–4  days) of detectable parasitemia by 
microscopy or RDT during which gametocyte carriage and effi-
ciency of transmission to mosquitoes would be expected to be 
the highest. Nevertheless, these infections seem to rapidly fall 
and stabilize at low parasitemia levels at which the efficiency 
of transmission to mosquitoes decreases [34]. Although in 
a control context this pool of infections could still contribute 
to transmission due to the abundance in the community [35], 
in elimination contexts, where the reservoir of asymptomatic 
infections in the community would decrease along wih the vec-
tor density as a result of the interventions deployed, the overall 
contribution of these remaining infections could decrease.
The ratio of infections detected by microscopy to those 
detected by qPCR rapidly decreased between day 0 and day 
28 from 0.9 to 0.52, suggesting that approximately half of the 
Table 2. Parasite Density Dynamics Assessed Through Poisson Regression Random-Effect Models of the Geometric Mean Parasite Density Variations 










Parasitemia by qPCR 
(95% CI)




Cumulative Probability of Failure, 
% (95% CI)
0 31 (31) 511.1 (279.1–935.9) 1
1 31 (31) 208.5 (101.0–430.6) 0.41 (.39–.41) 10 (0) 0.69 (.49–.81)
2 28 (30) 120.2 (51.3–281.8) 0.31 (.30–.31) 2 (2) 0.63 (.44–.58)
3 26 (28) 81.9 (39.8–168.6) 0.18 (.18–.19) 1 (0) 0.59 (.40–.74)
7 22 (24) 66.4 (28.5–154.6) 0.14 (.14–.14) 2 (1) 0.52 (.33–.68)
14 24 (26) 53.6 (24.2–118.8) 0.09 (.08–.09) 3 (0) 0.41 (.23–.58)
21 18 (22) 30.4 (12.2–76.0) 0.05 (.05–.05) 3 (0) 0.30 (.14–.47)
28 21 (25) 56.7 (18.3–175.4) 0.29 (.29–.30) 2 (1) 0.22 (.09–.39)
Abbreviations: CI, confidence interval; LFU, lost to follow-up; PCR, polymerase chain reaction; qPCR, quantitative polymerase chain reaction. 

























0 2 4 6 8 10 12 14 16 18 20 22 24 26 28
Days of follow-up
32 31 27 27 26 26 26 26 25 25 25 23 23 23 23
Number at risk
Figure 1. Kaplan–Meier estimates of the cumulative probability of parasite positivity by day 28 measured by quantitative polymerase chain reaction.
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afebrile infections may not be detected a few days after infection 
unless a more sensitive diagnostic tool is used. Blood samples 
that were positive by microscopy and qPCR had a GMPD of 
351.1 parasites/μL, compared with 13.8 parasites/μL observed 
in blood samples that were only positive by qPCR. In addi-
tion, we show that afebrile infections that become chronic in 
semi-immune adults linger below 100 parasites/μL and above 5 
parasites/μL based on the qPCR detection threshold.
Mathematical modeling of the data showed the Gompertz 
distribution as the best fit for P. falciparum natural infections, 
in line with previous reports [31, 32]. This distribution is widely 
used in demography and survival analysis because of its flexi-
bility. Nevertheless, the estimated duration of infection using 
the Gompertz distribution to model these data was much lower 
(41.6 days) than values previously reported in other studies using 
the same distribution (139.9–209.5 days) [31]. Different immu-
nity levels among individuals included in the datasets used for 
past models could partly explain these differences. However, the 
results presented here should be interpreted with caution given 
the limited fit identified through the Kolmogorov–Smirnov test 
Figure 2. Distributions of individual-level parasite densities observed for each day of follow-up of 32 afebrile Plasmodium falciparum–infected individuals over 28 days. 


















0 2 4 6 8 10 12 14 16 18 20 22 24 26 28
Days of follow-up
32 22 17 17 14 14 14 14 11 11 11 8 8 8 8
Number at risk
Figure 3. Kaplan–Meier estimates of the cumulative probability of failure to reduce parasitemia levels by at least 50% of their initial value—or half-life probability 
measured by quantitative polymerase chain reaction.
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for all distributions tested, as well as the reduced small sample 
size and lack of parasite clearance events observed throughout 
the study period. Similar modeling exercises using data from 
larger studies that are able to discern between reinfections and 
recrudescence would be required to fully demonstrate a good 
fit of any of the distributions evaluated here and to accurately 
predict duration of infection.
This analysis is subject to a series of limitations that should be 
considered when interpreting the results. First, the exact time 
at which each participant acquired the infection could not be 
assessed. Thus, the survival analysis was performed assuming 
the same duration of infection since recruitment for each indi-
vidual at every follow-up time point. A study using microscopy 
data had previously identified that untreated parasite densities 
in immune individuals tend to decrease in a short period of 
time, thus suggesting that infections that could still be identified 
through an RDT or microscopy could be considered recent and 
assumed to be of similar duration at the time of recruitment [16]. 
Our observation of a steep decline in parasitemia a few days after 
detection of infection by RDT further supports this assumption. 
However, we could not exclude the possibility that these were 
older infections detected as a result of parasite density oscilla-
tions. Second, the 28 days of follow-up limited our capacity to 
observe the natural dynamics of P. falciparum–untreated infec-
tions for a longer period of time. Third, the study did not collect 
extensive clinical data, such as hemoglobin levels, to assess the 
adverse impact of these afebrile (albeit not necessarily asympto-
matic) chronic infections [2]. Additionally, low parasitemia lev-
els precluded the molecular genotyping of infecting parasites to 
distinguish recrudescence from new infections [27, 36]. Finally, 
diurnal variations of body temperature, which may influence 
the fever estimates depending on the time when the measure-
ment is performed [37], were not assessed in this study.
In conclusion, this study suggests that afebrile P. falciparum 
infections in semi-immune adults tend to transform into sub-
microscopic infections soon after being detected by RDTs or 
microscopy. Although the role of these low-density infections in 
sustaining local transmission is still widely unknown, the asso-
ciation of gametocytemia with parasite biomass suggests a short 

































0 1 2 3 7 14 21 28
Days of follow-up
Positive by qPCR Positive by microscopy Microscopy to qPCR ratio
Figure 4. Proportion of positive samples by real-time quantitative polymerase chain reaction and microscopy per follow-up observation (bars, left y axis), and ratio of sam-
ples detected by polymerase chain reaction and microscopy through time (line, right y axis) during the follow-up of 32 afebrile Plasmodium falciparum–infected individuals 
at baseline. Abbreviation: qPCR, quantitative polymerase chain-reaction.
Table  3. Estimates of Parameters and Expected Lifetimes, the Akaike Information Criterion, the Kolmogorov-Smirnov Statistics, and the Estimated 
Proportion of Infected Individuals at Day 28 for the Exponential, Weibull, Log-Normal, and Gamma Distributions
Survival Distribution Scale Shape
Median
Lifetime AIC K-S (P value) % Infected at Day 28
Gompertz 0.084a 0.002 41.6 61.5 0.815 (<.001) 81.5%
Weibull 83.5 1.5 61.5 62.9 0.342 (<.001) 82.3%
Gamma 64.2 1.6 73.2 63.1 0.820 (<.001) 82.0%
Abbreviations: AIC, Akaike information criterion; K–S, Kolmogorov–Smirnov.
aRate.
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in parasite densities [33, 38]. Nevertheless, the infectivity of 
submicroscopic infections could also depend on the duration 
of infection, which we have estimated to range between 41.6 
and 73.2 days depending on the distribution used, but others 
have observed to be only a few weeks or as long as a few years 
[31], or on the parasite density oscillations over time. To con-
tribute to this question, this study also shows that natural infec-
tions follow a Gompertz distribution shape, which is crucial for 
the accurate prediction of infection duration at the commu-
nity level through mathematical modeling. Mass antimalarial 
administrations would sharply reduce the asymptomatic reser-
voir of infection and consequently decrease its contribution to 
transmission as a group. As more information is gathered about 
afebrile infections, its relevance in the context of malaria elim-
ination will be revealed, thus allowing policy makers to design 
and implement strategies that will target the main sources of 
transmission in the community in the race against this disease.
Supplementary Data
Supplementary materials are available at Clinical Infectious Diseases online. 
Consisting of data provided by the authors to benefit the reader, the posted 
materials are not copyedited and are the sole responsibility of the authors, 
so questions or comments should be addressed to the corresponding author.
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